Related Experiment Video
Updated: May 22, 2025

08:51
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
1.1K
Omega-3 index improves upon the pooled cohort equation in predicting risk for CVD
William G Franco1, Evan L O'Keefe1, James H O'Keefe1
1Saint Luke's Mid America Heart Institute, and University of Missouri-Kansas City, Kansas City, MO, USA (Drs Franco, E.L. O'Keefe, J.H. O'Keefe).
Journal of Clinical Lipidology
|March 12, 2025
Summary
The omega-3 index (O3I) improved atherosclerotic cardiovascular disease (ASCVD) risk prediction beyond the Pooled Cohort Equation (PCE). This suggests O3I can enhance ASCVD risk stratification for better patient outcomes.
Area of Science:
- Cardiology
- Preventive Medicine
- Biomarkers
Background:
- Accurate prediction of atherosclerotic cardiovascular disease (ASCVD) is vital for patient risk stratification.
- The Pooled Cohort Equation (PCE) is a standard tool, but its predictive accuracy for 10-year ASCVD risk is limited.
Purpose of the Study:
- To evaluate the omega-3 index (O3I) as a biomarker to improve ASCVD risk prediction.
- To determine if O3I enhances the predictive capability of the PCE.
Main Methods:
- The omega-3 index (O3I) was measured in 2550 participants from the Framingham Offspring Cohort.
- Area under the curve (AUC) analysis assessed the O3I's contribution to PCE predictions.
- O3I's added predictive power was evaluated with standard risk factors (blood pressure, diabetes, cholesterol, smoking).
Main Results:
- The PCE's AUC for predicting 10-year ASCVD events was 0.689.
- Adding the O3I to the PCE increased the AUC to 0.698 (P < .05).
- O3I significantly improved the predictive ability of individual risk factors when added to a basic age+sex+race model.
Conclusions:
- The omega-3 index (O3I) enhances ASCVD risk prediction beyond traditional factors assessed by the PCE.
- O3I shows potential as a valuable tool for improving ASCVD risk stratification.
- Further research in diverse populations is recommended to integrate O3I into clinical risk assessment.

